This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alexandrov, A. V. Articles by Grotta, J. C. Search for Related Content PubMed PubMed Citation Articles by Alexandrov, A. V. Articles by Grotta, J. C. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Nuclear Scans

(Stroke. 1997;28:1830-1834.)
© 1997 American Heart Association, Inc.

Articles

Brain Single-Photon Emission CT With HMPAO and Safety of Thrombolytic Therapy in Acute Ischemic Stroke

Proceedings of the Meeting of the SPECT Safe Thrombolysis Study Collaborators and the Members of the Brain Imaging Council of the Society of Nuclear Medicine

Andrei V. Alexandrov, MD; Joseph C. Masdeu, MD; Michael D. Devous, Sr, PhD; Sandra E. Black, MD, FRCP(C); James C. Grotta, MD

From the University of Texas at Houston (A.V.A., J.C.G.), New York (NY) Medical College (J.C.M.), the University of Texas at Dallas (M.D.D.), and the University of Toronto (Canada) (S.E.B., A.V.A.).

Correspondence to Dr Andrei Alexandrov, Stroke Program, University of Texas at Houston, MSB 7.044, 6431 Fannin St, Houston, TX 77030. E-mail avalexandrov{at}worldnet.att.net

Background To reliably identify patients at risk for symptomatic hemorrhagic transformation (SHT), future trials of thrombolysis for acute ischemic stroke might use a vascular imaging protocol applicable to a multicenter setting. The goal of this commentary is to address the safety of intravenous thrombolysis with the recombinant tissue plasminogen activator (rTPA) and potential solutions offered by single-photon emission CT (SPECT) as a noninvasive brain perfusion imaging modality.

Summary of Review Even if patients with severe stroke, extensive ischemic changes on CT scan, advanced age, and high blood pressure are excluded from thrombolytic therapy, this cannot completely guarantee the safety of using rTPA. Brain SPECT scanning with hexamethylpropyleneamine oxime (HMPAO) may help to screen out patients at risk if performed in addition to clinical and CT tests. The knowledge of pretreatment severity, extent, and location of ischemia might identify good versus poor responders to rTPA therapy. HMPAO-SPECT is widely available and feasible to perform without delaying rTPA therapy. Rigorous quality control and use of reproducible visual and semiquantitative methods of interpreting SPECT are necessary for implementation of SPECT technology in multicenter clinical trials.

Conclusions The major obstacle to general acceptance of thrombolytic therapies and rTPA in particular is the fear of symptomatic hemorrhagic transformation, and because HMPAO-SPECT might reliably identify patients at high risk of symptomatic hemorrhagic transformation, the clinical value of HMPAO-SPECT in patient selection for thrombolysis during the first hours of acute ischemic stroke should be determined through a prospective clinical trial.

Key Words: tissue plasminogen • thrombolytic therapy • tomography, emission computed

This article has been cited by other articles:

				M. Wintermark, M. Sesay, E. Barbier, K. Borbely, W. P. Dillon, J. D. Eastwood, T. C. Glenn, C. B. Grandin, S. Pedraza, J.-F. Soustiel, et al. Comparative Overview of Brain Perfusion Imaging Techniques Stroke, September 1, 2005; 36(9): e83 - e99. [Abstract] [Full Text] [PDF]

				A. Umemura, T. Suzuka, and K. Yamada Quantitative measurement of cerebral blood flow by 99mTc-HMPAO SPECT in acute ischaemic stroke: usefulness in determining therapeutic options J. Neurol. Neurosurg. Psychiatry, October 1, 2000; 69(4): 472 - 478. [Abstract] [Full Text] [PDF]

				A. V. Alexandrov and J. W. Norris SPECT in cerebrovascular disease Can. Med. Assoc. J., November 1, 1999; 161(9): 1135 - 1135. [Full Text] [PDF]

				T. Ueda, S. Sakaki, Y. Kumon, and S. Ohta Multivariable Analysis of Predictive Factors Related to Outcome at 6 Months After Intra-Arterial Thrombolysis for Acute Ischemic Stroke Stroke, November 1, 1999; 30 (11): 2360 - 2365. [Abstract] [Full Text] [PDF]

				M. Fisher and G. W. Albers Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke Neurology, June 1, 1999; 52(9): 1750 - 1750. [Abstract] [Full Text]

				J. Juni and Spicer Paradoxical Hyperfixation of HMPAO in Cerebral AJNR Am. J. Neuroradiol., May 1, 1999; 20(5): 732 - 733. [Full Text]

				Patterson, Hadley, and Wyper Another Spurious Description of Hypoerfixation of AJNR Am. J. Neuroradiol., May 1, 1999; 20(5): 941 - 942. [Full Text]